Concentrum Wealth Management Bio N Tech Se Transaction History

Concentrum Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$126.25 - $231.85 $124,861 - $229,299	-989 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$216.64 - $362.52 $1,733 - $2,900	-8 Reduced 0.8%	989 $255,000
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $42,833 - $93,023	-208 Reduced 17.26%	997 $272,000
Q2 2021 Jul 28, 2021	BUY	$113.32 - $241.49 $136,550 - $290,995	1,205 New	1,205 $270,000

340

40M

1.43M

1.54M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Concentrum Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Concentrum Wealth Management with notifications on news.